Evidence map›Paper›PMID 39302412›Full record

ReviewArchives of gynecology and obstetrics2024

Severe ovarian hyperstimulation syndrome following sole gonadotropin-releasing hormone (GnRH) agonist trigger: a case series and literature review.

Roza Berkovitz-Shperling, Nivin Samara, Reut Meir, Omri Dominsky, Foad Azem, Ido Feferkorn

Erratum issuedAbstract readCase ReportsReview
In one paragraph

Review in Archives of gynecology and obstetrics, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

6 authors.

Roza Berkovitz-ShperlingDepartment of Obstetrics and Gynecology, Lis Hospital for Women's Health, Tel Aviv. Sourasky Medical Center, affiliated to the Faculty of Medicine, Tel Aviv University, 6423906, Tel Aviv, Israel. raz.bershp@gmail.com.ORCID 0000-0002-2336-155X
Nivin SamaraDepartment of Obstetrics and Gynecology, Lis Hospital for Women's Health, Tel Aviv. Sourasky Medical Center, affiliated to the Faculty of Medicine, Tel Aviv University, 6423906, Tel Aviv, Israel.
Reut MeirDepartment of Obstetrics and Gynecology, Shaare Zedek Medical Center, 6 Weizman St., Affiliated to Faculty of Medicine, The Hebrew University of Jerusalem, Jerusalem, Israel.
Omri DominskyDepartment of Obstetrics and Gynecology, Lis Hospital for Women's Health, Tel Aviv. Sourasky Medical Center, affiliated to the Faculty of Medicine, Tel Aviv University, 6423906, Tel Aviv, Israel.
Foad AzemDepartment of Obstetrics and Gynecology, Lis Hospital for Women's Health, Tel Aviv. Sourasky Medical Center, affiliated to the Faculty of Medicine, Tel Aviv University, 6423906, Tel Aviv, Israel.
Ido FeferkornDepartment of Obstetrics and Gynecology, Lis Hospital for Women's Health, Tel Aviv. Sourasky Medical Center, affiliated to the Faculty of Medicine, Tel Aviv University, 6423906, Tel Aviv, Israel.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveThe aim of this study was to report three cases of early severe ovarian hyperstimulation syndrome (OHSS) in patients undergoing a GnRH antagonist protocol triggered with GnRH agonist (GnRH-a), leading to hospitalization and the need for peritoneal drainage. Additionally, a review of the existing literature on this topic is provided.

designThis is a retrospective case series and a literature review.

settingThis study was conducted at obstetrics and gynecology department of tertiary academic referral hospitals, Israel.

participantsThis study included three patients presented with severe OHSS symptoms, including abdominal distension, ascites, and hemoconcentration.

main outcome measuresThe main focus of the treatment was to address the symptoms and prevent any further complications. The outcome was the complete recovery of the patients.

resultsThe presented cases detail instances of severe OHSS following oocyte retrieval, utilizing GnRH-a for triggering. Case 1 involved a 33-year-old patient with a history of polycystic ovary syndrome (PCOS), Case 2 featured a 22-year-old patient with familial adenomatous polyposis (FAP), and Case 3 included a 41-year-old patient with a history of depressive disorder. All patients receiving supportive care, including infusions and medications, exhibited gradual improvement during hospitalization, with complete resolution observed during the 20-day post-hospitalization check-up.

conclusionsThese three cases highlight the occurrence of severe early OHSS following a GnRH antagonist protocol triggered with GnRH-a in the absence of human chorionic gonadotropin (hCG) administration for trigger or luteal-phase support. Clinicians must be aware that a GnRH-a trigger followed by a freeze-all approach does not guarantee the complete elimination of OHSS in all patients.

Indexed as

Gonadotropin-Releasing HormoneOvarian Hyperstimulation SyndromeAdultFemaleFertility Agents, FemaleHumansOocyte RetrievalOvulation InductionPolycystic Ovary SyndromeRetrospective StudiesYoung AdultFertility Agents, FemaleGonadotropin-Releasing HormoneGnRH agonist triggeringGnRH antagonistOvarian hyperstimulation syndrome

Identifiers

PMID39302412
PMCPMC11485447

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.